当前位置： SCI文献检索 > BMC INFECTIOUS DISEASES期刊下所有文献 > Successful implementation of isoniazid preventive therapy at a pediatric HIV clinic in Tanzania.

Successful implementation of isoniazid preventive therapy at a pediatric HIV clinic in Tanzania.

Abstract：

BACKGROUND:In accordance with international guidance for tuberculosis (TB) prevention, the Tanzanian Ministry of Health recommends isoniazid preventive therapy (IPT) for children aged 12 months and older who are living with HIV. Concerns about tolerability, adherence, and potential mistreatment of undiagnosed TB with monotherapy have limited uptake of IPT globally, especially among children, in whom diagnostic confirmation is challenging. We assessed IPT implementation and adherence at a pediatric HIV clinic in Tanzania. METHODS:In this prospective cohort study, eligible children living with HIV aged 1-15 years receiving care at the DarDar Pediatric Program in Dar es Salaam who screened negative for TB disease were offered a 6-month regimen of daily isoniazid. Patients could choose to receive IPT via facility- or community-based care. Parents/caregivers and children provided informed consent and verbal assent respectively. Isoniazid was dispensed with the child's antiretroviral therapy every 1-3 months. IPT adherence and treatment completion was determined by pill counts, appointment attendance, and self-report. Patients underwent TB symptom screening at every visit. RESULTS:We enrolled 66 children between July and December 2017. No patients/caregivers declined IPT. Most participants were female (n = 43, 65.1%) and the median age was 11 years (interquartile range [IQR] 8, 13). 63 (95.5%) participants chose the facility-based model; due to the small number of participants who chose the community-based model, valid comparisons between the two groups could not be made. Forty-nine participants (74.2%) completed IPT within 10 months. Among the remaining 17, 11 had IPT discontinued by their provider due to adverse drug reactions, 5 lacked documentation of completion, and 1 had unknown outcomes due to missing paperwork. Of those who completed IPT, the average monthly adherence was 98.0%. None of the participants were diagnosed with TB while taking IPT or during a median of 4 months of follow-up. CONCLUSIONS:High adherence and treatment completion rates can be achieved when IPT is integrated into routine, self-selected facility-based pediatric HIV care. Improved record-keeping may yield even higher completion rates. IPT was well tolerated and no cases of TB were detected. IPT for children living with HIV is feasible and should be implemented throughout Tanzania.

journal_name

BMC Infect Dis

journal_title

BMC infectious diseases

authors

Hunter OF,Kyesi F,Ahluwalia AK,Daffé ZN,Munseri P,von Reyn CF,Adams LV

doi

10.1186/s12879-020-05471-z

subject

Has Abstract

pub_date

2020-10-07 00:00:00

pages

738

issue

issn

1471-2334

pii

10.1186/s12879-020-05471-z

journal_volume

pub_type

杂志文章

在线工具

Successful implementation of isoniazid preventive therapy at a pediatric HIV clinic in Tanzania.